Ardea Biosciences, Inc.

Having jumped in front of the UK's Redx Pharma Plc to snap up Jounce Therapeutics, Inc. , Concerta Biosciences is looking to bag another embattled biotech, making a bid for the US antiviral speci

Less than a month after laying off half its staff and leaping onto a life raft thrown by Redx Pharma Plc , Jounce Therapeutics, Inc. has received a takeover offer from another suitor, little-known

The convergence of the COVID-19 pandemic and the 3 November presidential elections has US Food and Drug Administration observers wondering whether the agency might approve or authorize a vaccine befor

Relay Therapeutics has raised $520m in venture capital since 2016, including a $400m Series C round announced on Dec. 20, without relaying a lot of information publicly about how it will translate it